Legal status · Canada
Is Carbetocin (intranasal) legal in Canada?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
No. Carbetocin (intranasal) is not approved for any medical use in Canada; its classification is "Investigational, not approved". Lawful access is limited to registered clinical trials. "Research use only" labeling on vials sold online does not make human use lawful. On the evidence, 4 human studies are cited on its profile.
Carbetocin (intranasal) in Canada at a glance
| Classification | Investigational, not approved |
|---|---|
| Note | Not authorised in this formulation. Injectable carbetocin for postpartum haemorrhage is a separate product. |
| Health Canada approval status | Not approved by Health Canada; investigational |
| Human studies cited | 4 of 4 citations on the profile |
| Reviewed | Sep 2026 |
Classification and note come from the Carbetocin (intranasal) profile, checked against Health Canada, Health Products and Food Branch (Health Canada) listings at the reviewed date.
What this means
- 01
Carbetocin (intranasal) is being studied in registered clinical trials but has not received Health Canada marketing approval in Canada.
- 02
Lawful human access is limited to trial participation or a formal early-access scheme where one exists; there is no pharmacy product to prescribe.
- 03
Vials sold online "for research use only" are not trial material, and that label does not make human use lawful.
What Carbetocin (intranasal) is
A failed programme, reported as one. Both phase 3 trials in Prader-Willi syndrome missed their primary endpoint, the confirmatory trial returned a treatment difference of 0.3 points on hyperphagia with P = 0.79 and a point estimate favouring placebo, and the open-label extension was terminated by the sponsor for futility.
This entry exists because intranasal carbetocin is frequently cited as evidence that oxytocin-pathway drugs work on behaviour. The trials it is cited from failed.
Mechanism: The oxytocin receptor agonism is established pharmacology. Carbetocin binds the oxytocin receptor with greater selectivity and a longer duration than oxytocin, which is the whole point of the molecule.
Regulatory history: Not approved. An openFDA drug-label query for the generic name carbetocin returns no matches, consistent with no approved United States product. After the confirmatory phase 3 failure and the termination of the extension study, there is no active path to approval for the intranasal formulation.
How Health Canada treats this kind of product
Authorises drugs for sale through a Notice of Compliance and Drug Identification Number. A compound that is not authorised for sale cannot lawfully be sold for human use, and personal importation of prescription drugs is limited.
The classification above is the The Longevity Archive reading of Health Canada, Health Products and Food Branch listings for Carbetocin (intranasal) at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Carbetocin (intranasal) in other countries
United States
Not approvedInvestigational, not approved
Is Carbetocin (intranasal) legal in the United States?United Kingdom
Not approvedInvestigational, not licensed
Is Carbetocin (intranasal) legal in the United Kingdom?Australia
Not approvedInvestigational, not registered
Is Carbetocin (intranasal) legal in Australia?Frequently asked questions
Is Carbetocin (intranasal) legal in Canada?
No. Carbetocin (intranasal) is not approved for any medical use in Canada; its classification is "Investigational, not approved". Lawful access is limited to registered clinical trials. "Research use only" labeling on vials sold online does not make human use lawful. On the evidence, 4 human studies are cited on its profile. Note: Not authorised in this formulation. Injectable carbetocin for postpartum haemorrhage is a separate product.
Can I buy Carbetocin (intranasal) in Canada?
No approved product exists to buy. In Canada Carbetocin (intranasal) is classified as "Investigational, not approved", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors. Note: Not authorised in this formulation. Injectable carbetocin for postpartum haemorrhage is a separate product.
Is Carbetocin (intranasal) Health Canada approved?
No. In Canada Carbetocin (intranasal) is classified as "Investigational, not approved", which is not a Health Canada marketing approval. For comparison, the US FDA status is: Not approved. An openFDA drug-label query for the generic name carbetocin returns no matches, consistent with no approved United States product. After the confirmatory phase 3 failure and the termination of the extension study, there is no active path to approval for the intranasal formulation.. On the evidence, 4 human studies are cited on its profile.
Related compounds in Canada
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Carbetocin (intranasal) live on its compound profile.
Carbetocin (intranasal) profileThis page is general information about the regulatory status of Carbetocin (intranasal) in Canada, current as of Sep 2026. It is not legal advice, and classifications change; check Health Canada, Health Products and Food Branch directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.